Perimenopause Hype Outpaces Scientific Certainty

Perimenopause, the transitional phase leading up to menopause, is increasingly discussed in popular culture and online, often accompanied by claims of readily available diagnostic tests and targeted treatments. However, medical professionals and researchers emphasize that the understanding and management of perimenopause are more complex than often portrayed. Menopause is clinically defined as the point one year after a person's last menstrual period, with perimenopause encompassing the preceding years characterized by fluctuating hormone levels and associated symptoms.

Many women in their mid-to-late 40s, around age 46 or 47, begin to experience symptoms such as hot flashes, irregular or heavy periods, and anxiety, which are often attributed to perimenopause. These symptoms can be particularly intense during this phase due to significant hormonal fluctuations. Estrogen, progesterone, luteinizing hormone, and follicle-stimulating hormone levels can vary widely before stabilizing post-menopause. This variability is a key reason why, according to experts like Mary Ann Lumsden, former president of the International Menopause Society, there is no definitive diagnostic test for perimenopause itself.

Lumsden explains that hormone levels fluctuate so much during perimenopause that "you can't interpret hormone [measures] because they change so much," adding that such changes are "quite normal." This scientific perspective contrasts with the marketing of numerous blood tests, apps, and supplements that claim to diagnose or manage perimenopause. While the discomfort of perimenopausal symptoms is acknowledged, the prevalence of misinformation can lead to unnecessary spending and potentially ineffective interventions. The focus on symptom relief remains important, but the diagnostic and treatment landscape is often clouded by oversimplification and commercial interests.